Although corticosteroids are the standard first therapy for chronic cGVHD (Graft Versus Host Disease), and multiple second-line treatments have been evaluated for patients who are steroid-refractory or steroid-intolerant, what role does ECP play?

Although corticosteroids are the standard first therapy for chronic cGVHD (Graft Versus Host Disease), and multiple second-line treatments have been evaluated for patients who are steroid-refractory or steroid-intolerant, what role does ECP play?

CLICK HERE FOR CME CREDIT

Although corticosteroids are the standard first therapy for chronic cGVHD (Graft Versus Host Disease), and multiple second-line treatments have been evaluated for patients who are steroid-refractory or steroid-intolerant, what role does ECP play?

Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Daniel Couriel, MD, MS

Daniel Couriel, MD, MS

Daniel R. Couriel, MD, MS
Professor of Internal Medicine
Director, Huntsman Cancer Institute (HCI) Blood and Marrow Transplant Program
University of Utah School of Medicine
Salt Lake City, UT